Cure8

Why This Matters

If dietary oxalate influences gut inflammation, it could be a modifiable dietary factor for some people with IBD and might help explain variability in symptoms. The study points to transporters as potential markers of sensitivity and disease behavior, which could guide future personalized dietary approaches.

Who Should Pay Attention

Adult patients with Crohn’s disease or ulcerative colitis, gastroenterologists, IBD dietitians, and researchers studying diet–inflammation interactions and biomarkers in IBD.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

This study combines patient cohort data and mouse/experimental models. In human IBD tissue and stool, investigators measured gene expression, stool oxalate, and dietary intake; in mice they tested effects of an oxalate-supplemented diet on disease activity.

Across samples, several oxalate transporters were reduced in IBD, stool oxalate tended to be higher in Crohn’s patients, and increased dietary oxalate in mice was linked to worse colitis. These findings do not establish that dietary oxalate causes flares in people with IBD.

The report identifies associations in human samples and experimental effects in animals and cell systems that support a biological link worth clinical study. It suggests transporter expression might help identify individuals who are more sensitive to dietary oxalate, but this is preliminary.

If you are thinking about dietary changes, discuss them with your clinician or dietitian before making restrictions; this paper does not provide clinical guidance or proven dietary prescriptions.

Keep In Mind

This record is an abstract-based summary of a journal article combining human cohort measurements and experimental mouse/cell studies. Results from animal and ex vivo models don’t prove the same effects occur in people; the authors call for further research. The paper does not provide clinical dietary recommendations.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationCellular and molecular gastroenterology and hepatology
AuthorsAnna C Salvador, Zena Khaled, Ayesh Awad +26 more
InstitutionCenter for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedAug 13, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →